The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists

Ophthalmic Epidemiology

Volumn 13, Issue 4, 2006, Pages 263-274

  Clegg, John ^a   Guest, Julian ^a,b   Lehman, Almut ^a   Smith, Andrew ^c,d  

^a CATALYST Health Economics Consultants   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c Alcon Laboratories Ltd UK   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Costs; Dry eye; Economics; France; Germany; Italy; Resource use; Spain; Sweden; UK

Indexed keywords

CARBOMER; CARBOXYMETHYLCELLULOSE; CYCLOSPORIN; DEXTRAN; HYALURONIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC TROMETAMOL; OXYMETAZOLINE; PARAFFIN; POLYVINYL ALCOHOL; POVIDONE; POVIDONE IODINE; SODIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRY EYE; EYE SURGERY; FRANCE; GENERAL PRACTITIONER; GERMANY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; ITALY; OPHTHALMOLOGY; PREVALENCE; PRIORITY JOURNAL; SPAIN; SWEDEN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; DRY EYE SYNDROMES; GERMANY; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; ITALY; MIDDLE AGED; OPHTHALMOLOGY; PREVALENCE; RETROSPECTIVE STUDIES; SPAIN; SWEDEN;

EID: 33746843606     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580600801044     Document Type: Article

References (36)

1. Goto E, Yago Y, Matsumoto Y, Tubota K. Impaired functional visual acuity of dry eye patients. Am J Opthal. 2002;133(2):181-186.
2. Cohen EJ. Corneal and external disease in the new millennium. Arch Opthal. 2000;118(7):979-981.
3. Ram J, Sharma A, Pandav SS, Gupta A, Bambery P. Cataract surgery in patients with dry eyes. J Cataract & Refr Surg. 1998;24(8):1119-1124.
4. Nelson JD. A clinician looks at the tearfilm. Adv Exp Med & Biol. 1998;438:1-9.
5. Moss SE, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthal. 2000;118(9):1264-1268.
6. Shimmura S, Shimzaki J, Tsubota K. Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea. 1999;18(4):408-411.
7. Brewitt H, Sistani F. Dry eye disease: The scale of the problem. Surv Ophthalmol. 2001;45(suppl 2):S199-S202.
8. Begley CG, Caffery B, Nichols K, Mitchell Gl, Chalmers R. Results of a dry eye questionnaire from optometric practices in North America. Adv Exp Med & Bio. 2002;506:1009-1016.
9. Calogne M. The treatment of dry eye. Surv Opthal. 2001;45(suppl 2):S227-S239.
10. Pray WS. Self-treatment for minor eye conditions. US Pharmacist. 2001;26(12).
11. Pflugfelder SC, Solomon S, Stern ME. The diagnosis and management of dry eye: A 25-year review. Cornea. 2000;19(5):644-649.
12. Hirsch JD. Considerations in the pharmacoeconomics of dry eye. Manag Care. 2003;12(12 Suppl):33-38.
13. Dalzell MD. Dry eye: Prevalence, utilization, and economic implications. Manag Care. 2003;12(12 Suppl):9-13.
14. British National Formulary 2004. (http://www.bnf.org).
15. Dictionnaire Vidal, Paris 2004. (http://www.vidal.fr).
16. Rote Liste 2004. (http://www.rote-liste.de).
17. Giofil Banca Dati Sanitaria Farmaceutica 2004. (www.giofil.it).
18. Vademécum Internacional 2004. (http://vademecum.medicom.es).
19. Läkemedelsförmånsnämnden 2004. (http://www.lfn.se).
20. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthal. 1998;105(6):1114-1119.
21. Balaram M, Schaumberg DA, Dana M R. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol. 2001;131:30-36.
22. Tai, M., Cosar CB, Cohen EJ, Rapnano CJ, Laibson PR. The clinical efficacy of silicone punctal plug therapy. Cornea. 2002;21:135-139.
23. Shiell A. Cost of illness studies: No aid to decision making? Health Policy. 1987;8:317-323.
24. Nichols JJ, Begley CG, Caffrey B, Jones LA. Symptoms of ocular irritation in patients diagnosed with dry eye. Optom Vis Sci. 1999;76(12):838-844.
25. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med & Biol. 2002;506(Pt B):989-998.
26. Schein OD, Munuz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthal. 1997;124(6):723-728.
27. Lemp MA. Epidemiology and classification of dry eye. Adv Exp Med & Bio. 1998;438:791-803.
28. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74(8):624-631.
29. Yazdani C, McLaughlin T, Smeeding JE, Walt J. Prevalence of treated dry eye disease in a managed care population. Clin Ther 2001;23(10):1672-1682.
30. Schmut O, Huber H, Mullner K, Haller EM, Faulborn J. Investigations on the increase of the dry eye syndrome in the years 1960-1994. Spektrum der Augenheilkunde. 1995;9(2):90-91.
31. Stevens A, Raftery J. Introduction. In: Stevens, A, Raftery, J., editors, Health Care Needs Assessment. The Epidemiologically Based Needs Assessment Reviews, Vol. 1. Oxford: Radcliffe Medical Press, 11-30.
32. Das Gupta R, Guest JF. The annual cost of bipolar disorder to UK society. Br J Psych. 2002;180:227-233.
33. Guest JF, Cookson RF. Cost of schizophrenia to UK society: An incidence-based cost of illness model for the first five years following diagnosis. PharmacoEconomics. 1999;15(6):597-610.
34. Guest JF. The annual cost of chronic obstructive pulmonary disease to the UK's National Health Service. Dis Manag Health Outcomes. 1999;5(2):93-100.
35. Plumb JM, Guest JF. Annual cost of erectile dysfunction to UK society. PharmacoEconomics. 1999;16(6):699-709.
36. National Institute for Clinical Excellence. Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care, Clinical Guideline 12 February 2004. (http://www.nice.org.uk/CG012NICEguideline).